Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Amplification Technologies
1.2.3 Amplified Gene Detection Technologies
1.2.4 DNA And Oligonucleotide Microarrays
1.2.5 Gene Sequencing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics and NAT Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics and NAT Market Perspective (2018-2033)
2.2 Molecular Diagnostics and NAT Growth Trends by Region
2.2.1 Global Molecular Diagnostics and NAT Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Diagnostics and NAT Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnostics and NAT Forecasted Market Size by Region (2024-2033)
2.3 Molecular Diagnostics and NAT Market Dynamics
2.3.1 Molecular Diagnostics and NAT Industry Trends
2.3.2 Molecular Diagnostics and NAT Market Drivers
2.3.3 Molecular Diagnostics and NAT Market Challenges
2.3.4 Molecular Diagnostics and NAT Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics and NAT Players by Revenue
3.1.1 Global Top Molecular Diagnostics and NAT Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics and NAT Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics and NAT Revenue
3.4 Global Molecular Diagnostics and NAT Market Concentration Ratio
3.4.1 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics and NAT Revenue in 2022
3.5 Molecular Diagnostics and NAT Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics and NAT Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics and NAT Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics and NAT Breakdown Data by Type
4.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2024-2033)
5 Molecular Diagnostics and NAT Breakdown Data by Application
5.1 Global Molecular Diagnostics and NAT Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Diagnostics and NAT Market Size (2018-2033)
6.2 North America Molecular Diagnostics and NAT Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Diagnostics and NAT Market Size by Country (2018-2023)
6.4 North America Molecular Diagnostics and NAT Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics and NAT Market Size (2018-2033)
7.2 Europe Molecular Diagnostics and NAT Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Diagnostics and NAT Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnostics and NAT Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics and NAT Market Size (2018-2033)
8.2 Asia-Pacific Molecular Diagnostics and NAT Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics and NAT Market Size (2018-2033)
9.2 Latin America Molecular Diagnostics and NAT Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Diagnostics and NAT Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnostics and NAT Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics and NAT Market Size (2018-2033)
10.2 Middle East & Africa Molecular Diagnostics and NAT Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Molecular Diagnostics and NAT Introduction
11.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Molecular Diagnostics and NAT Introduction
11.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Molecular Diagnostics and NAT Introduction
11.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.3.5 BD Recent Development
11.4 Biomerieux
11.4.1 Biomerieux Company Detail
11.4.2 Biomerieux Business Overview
11.4.3 Biomerieux Molecular Diagnostics and NAT Introduction
11.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.4.5 Biomerieux Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Molecular Diagnostics and NAT Introduction
11.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Introduction
11.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent Molecular Diagnostics and NAT Introduction
11.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.7.5 Agilent Recent Development
11.8 GenMark
11.8.1 GenMark Company Detail
11.8.2 GenMark Business Overview
11.8.3 GenMark Molecular Diagnostics and NAT Introduction
11.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.8.5 GenMark Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Detail
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Molecular Diagnostics and NAT Introduction
11.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.9.5 Siemens Healthcare Recent Development
11.10 AutoGenomics
11.10.1 AutoGenomics Company Detail
11.10.2 AutoGenomics Business Overview
11.10.3 AutoGenomics Molecular Diagnostics and NAT Introduction
11.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2018-2023)
11.10.5 AutoGenomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Amplification Technologies
Table 3. Key Players of Amplified Gene Detection Technologies
Table 4. Key Players of DNA And Oligonucleotide Microarrays
Table 5. Key Players of Gene Sequencing
Table 6. Global Molecular Diagnostics and NAT Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Molecular Diagnostics and NAT Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Molecular Diagnostics and NAT Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Molecular Diagnostics and NAT Market Share by Region (2018-2023)
Table 10. Global Molecular Diagnostics and NAT Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Molecular Diagnostics and NAT Market Share by Region (2024-2033)
Table 12. Molecular Diagnostics and NAT Market Trends
Table 13. Molecular Diagnostics and NAT Market Drivers
Table 14. Molecular Diagnostics and NAT Market Challenges
Table 15. Molecular Diagnostics and NAT Market Restraints
Table 16. Global Molecular Diagnostics and NAT Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Molecular Diagnostics and NAT Market Share by Players (2018-2023)
Table 18. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics and NAT as of 2022)
Table 19. Ranking of Global Top Molecular Diagnostics and NAT Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Molecular Diagnostics and NAT Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnostics and NAT Product Solution and Service
Table 23. Date of Enter into Molecular Diagnostics and NAT Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnostics and NAT Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2018-2023)
Table 27. Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2024-2033)
Table 29. Global Molecular Diagnostics and NAT Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Molecular Diagnostics and NAT Revenue Market Share by Application (2018-2023)
Table 31. Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Molecular Diagnostics and NAT Revenue Market Share by Application (2024-2033)
Table 33. North America Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Molecular Diagnostics and NAT Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Molecular Diagnostics and NAT Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Molecular Diagnostics and NAT Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Molecular Diagnostics and NAT Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnostics and NAT Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Molecular Diagnostics and NAT Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Molecular Diagnostics and NAT Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2024-2033) & (US$ Million)
Table 48. Roche Company Detail
Table 49. Roche Business Overview
Table 50. Roche Molecular Diagnostics and NAT Product
Table 51. Roche Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Abbott Company Detail
Table 54. Abbott Business Overview
Table 55. Abbott Molecular Diagnostics and NAT Product
Table 56. Abbott Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. BD Company Detail
Table 59. BD Business Overview
Table 60. BD Molecular Diagnostics and NAT Product
Table 61. BD Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 62. BD Recent Development
Table 63. Biomerieux Company Detail
Table 64. Biomerieux Business Overview
Table 65. Biomerieux Molecular Diagnostics and NAT Product
Table 66. Biomerieux Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 67. Biomerieux Recent Development
Table 68. Qiagen Company Detail
Table 69. Qiagen Business Overview
Table 70. Qiagen Molecular Diagnostics and NAT Product
Table 71. Qiagen Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 72. Qiagen Recent Development
Table 73. Thermo Fisher Scientific Company Detail
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Molecular Diagnostics and NAT Product
Table 76. Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Agilent Company Detail
Table 79. Agilent Business Overview
Table 80. Agilent Molecular Diagnostics and NAT Product
Table 81. Agilent Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 82. Agilent Recent Development
Table 83. GenMark Company Detail
Table 84. GenMark Business Overview
Table 85. GenMark Molecular Diagnostics and NAT Product
Table 86. GenMark Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 87. GenMark Recent Development
Table 88. Siemens Healthcare Company Detail
Table 89. Siemens Healthcare Business Overview
Table 90. Siemens Healthcare Molecular Diagnostics and NAT Product
Table 91. Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 92. Siemens Healthcare Recent Development
Table 93. AutoGenomics Company Detail
Table 94. AutoGenomics Business Overview
Table 95. AutoGenomics Molecular Diagnostics and NAT Product
Table 96. AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2018-2023) & (US$ Million)
Table 97. AutoGenomics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics and NAT Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Molecular Diagnostics and NAT Market Share by Type: 2022 VS 2033
Figure 3. Amplification Technologies Features
Figure 4. Amplified Gene Detection Technologies Features
Figure 5. DNA And Oligonucleotide Microarrays Features
Figure 6. Gene Sequencing Features
Figure 7. Global Molecular Diagnostics and NAT Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Molecular Diagnostics and NAT Market Share by Application: 2022 VS 2033
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Molecular Diagnostics and NAT Report Years Considered
Figure 13. Global Molecular Diagnostics and NAT Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Molecular Diagnostics and NAT Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Molecular Diagnostics and NAT Market Share by Region: 2022 VS 2033
Figure 16. Global Molecular Diagnostics and NAT Market Share by Players in 2022
Figure 17. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics and NAT as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Molecular Diagnostics and NAT Revenue in 2022
Figure 19. North America Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Molecular Diagnostics and NAT Market Share by Country (2018-2033)
Figure 21. United States Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Molecular Diagnostics and NAT Market Share by Country (2018-2033)
Figure 25. Germany Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Molecular Diagnostics and NAT Market Share by Region (2018-2033)
Figure 33. China Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Molecular Diagnostics and NAT Market Share by Country (2018-2033)
Figure 41. Mexico Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Molecular Diagnostics and NAT Market Share by Country (2018-2033)
Figure 45. Turkey Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Molecular Diagnostics and NAT Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 48. Abbott Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 49. BD Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 50. Biomerieux Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 51. Qiagen Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 53. Agilent Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 54. GenMark Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 55. Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 56. AutoGenomics Revenue Growth Rate in Molecular Diagnostics and NAT Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed